Beyond Alzheimer's: Why we need to talk about Vascular Dementia (VD) and taVNS

While most attention focuses on Alzheimer's Disease (AD), we urgently need to shine a spotlight on Vascular Dementia (VD)—a condition deeply intertwined with our daily lifestyle choices.

Vascular Dementia is the second most common form of dementia, accounting for approximately 17-30% of all dementia cases, caused by reduced blood flow to the brain due to damaged blood vessels.

Unlike Alzheimer's Disease, VD is directly linked to cerebrovascular disease and is often preventable through lifestyle interventions. This makes it a particularly important target for proactive health management, especially given its significant prevalence.

We have far greater power to prevent VD than many of us realize.

The Deep Connection to Daily Life

The development of VD is closely tied to our cardiovascular health, including conditions like hypertension, diabetes, and heart disease. Our daily habits play a crucial role too—what we eat, how much we exercise, our sleep quality, and how we manage stress all directly impact our risk. Most importantly, the integrity of our cerebrovascular system, which includes blood vessel health and brain circulation, determines our vulnerability to this condition.

The Autonomic Nervous System Factor

Recent research reveals that cerebrovascular disease is intimately connected to autonomic nervous system resilience. When our body struggles to control inflammation, chronic inflammatory processes damage blood vessels throughout the brain. Poor blood pressure regulation accelerates this vascular damage, while autonomic dysfunction directly affects cerebral blood flow, creating a cascade of problems that can lead to cognitive decline.

How taVNS Technology Offers Help

Transcutaneous Vagus Nerve Stimulation (taVNS) offers a promising intervention by working on multiple fronts simultaneously. It helps modulate autonomic nervous system function, bringing better balance to our body's automatic processes. The technology also reduces systemic inflammation throughout the body, supports healthier blood pressure regulation, and ultimately enhances cerebrovascular health—addressing the root causes rather than just symptoms.

Current Clinical Research Status

Ongoing clinical trials demonstrate growing scientific interest in taVNS for vascular cognitive impairment. A current randomized controlled trial at Yangtze University (Trial ID: ChiCTR2300076632) is investigating the combined effects of tDCS and taVNS on poststroke cognitive impairment—a condition closely related to vascular dementia.

The study involves 66 patients with poststroke cognitive impairment, divided into three treatment groups: tDCS alone, taVNS alone, and combined therapy. Each participant receives 30 minutes of treatment daily, 5 times weekly for 3 weeks. Researchers conduct comprehensive assessments using the Montreal Cognitive Assessment, neuropsychological testing, and advanced neuroimaging including fMRI and DTI. This rigorous clinical approach exemplifies the evidence-based development of taVNS technology for vascular-related cognitive conditions.

While the potential benefits are promising, more clinical data is needed to fully establish taVNS efficacy for vascular dementia. Current research shows encouraging results of taVNS on sleep problems, GI problems, stress, and depression, but comprehensive clinical trials remain essential before we can make definitive claims about its effectiveness.

A Complete Wellness Strategy, Moving Forward Together

Alongside traditional interventions like maintaining a healthy diet, getting quality sleep, engaging in regular exercise, and managing emotional well-being, taVNS represents a potential technological support for vascular dementia prevention and management. Rather than replacing these foundational health practices, it works synergistically with them to provide a more comprehensive approach to brain health.

Beyond AD, we do need to pay attention to VD. The path forward requires a comprehensive approach that combines lifestyle interventions with innovative technologies. Better sleep is fundamental—quality rest allows our brain's glymphatic system to clear metabolic waste and reduces inflammation that damages blood vessels. Healthy nutrition rich in anti-inflammatory foods, omega-3 fatty acids, and antioxidants directly supports vascular health and cognitive function. Regular exercise improves circulation, reduces blood pressure, and promotes neuroplasticity while strengthening our cardiovascular system.

Perhaps most critically, chronic stress management plays a pivotal role in vascular dementia prevention. Persistent elevated cortisol responses create a state of chronic inflammation, elevate blood pressure, and impair autonomic nervous system function—all key factors in vascular cognitive decline. This is where taVNS technology shows particular promise, as it can help regulate these stress responses while supporting the body's natural healing mechanisms.

By integrating these lifestyle foundations with innovative interventions like taVNS, we create a powerful synergy for brain health preservation. Each element reinforces the others: better sleep improves stress resilience, exercise enhances the benefits of good nutrition, stress management supports quality sleep, and taVNS technology can amplify all these positive effects through its influence on the autonomic and central nervous systems.

Reference:

[1] https://www.alzint.org/about/dementia-facts-figures/types-of-dementia/vascular-dementia/?utm_source=chatgpt.com

[2] Hurła, M., Banaszek, N., Kozubski, W., & Dorszewska, J. (2025). Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features. Current Alzheimer Research, 22(1), 2-18.

[3] Liu, W., Cheng, X., Zhang, Y., & Liao, W. (2024). Effect of transcranial direct current stimulation combined with transcutaneous auricular vagus nerve stimulation on poststroke cognitive impairment: a study protocol for a randomised controlled trial. BMJ open, 14(4), e082764.